Effect of adjuvant tamoxifen therapy on thyroid function in postmenopausal women with breast cancer

被引：23
|
作者：
Zidan, J
Rubenstein, W
机构：
[1] Rebecca Sief Govt Hosp, Oncol Unit, IL-13100 Safed, Israel
[2] Technion Israel Inst Technol, Fac Med, Haifa, Israel
来源：
ONCOLOGY | 1999年 / 56卷 / 01期
关键词：
tamoxifen; adjuvant therapy; breast cancer; thyroid function;
D O I：
10.1159/000011928
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Serum thyroid-stimulating hormone (TSH), free thyroxine (FT4) and total tri-iodothyronine (TT3) concentrations were measured in 45 postmenopausal breast cancer patients before adjuvant treatment with tamoxifen and at 3- and 6-month intervals, A significant increase in TSH (p = 0.002) at the end of 3 months and a subsequent decrease at the end of 6 months was noted. There were no significant changes in TT3 and FT4. We concluded that tamoxifen therapy in postmenopausal women may result in a reversible increase in TSH after 3 months.
引用
收藏
页码：43 / 45
页数：3
相关论文
共 50 条
  • [1] The effect of adjuvant tamoxifen therapy in postmenopausal women on thyroid function tests
    Zidan, J
    Robenstein, W
    Amira, A
    Jobani, R
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 75 - 75
  • [2] THYROID-FUNCTION TEST CHANGES WITH ADJUVANT TAMOXIFEN THERAPY IN POSTMENOPAUSAL WOMEN WITH BREAST-CANCER
    MAMBY, CC
    LOVE, RR
    LEE, KE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (04) : 854 - 857
  • [3] Thyroid function in postmenopausal women with breast cancer on tamoxifen
    Kostoglou-Athanassiou, I
    Ntalles, K
    Markopoulos, C
    Athanassiou, P
    Gogas, J
    Proukakis, C
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 1998, 19 (02) : 150 - 154
  • [4] Operabile breast cancer in postmenopausal women on adjuvant antiestrogen tamoxifen
    Veselinovic, S
    Filipovic, S
    Projevic, M
    Stojanovic, D
    Buric, M
    [J]. BALKAN CONGRESS OF ONCOLOGY, 1996, : 447 - 450
  • [5] Thyroid function in postmenopausal breast cancer patients treated with tamoxifen
    Anker, GB
    Lonning, PE
    Aakvaag, A
    Lien, EA
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1998, 58 (02): : 103 - 107
  • [6] Effect of local therapy on locoregional recurrence in postmenopausal women with breast cancer in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial
    van Hezewijk, Marjan
    Bastiaannet, Esther
    Putter, Hein
    Scholten, Astrid N.
    Liefers, Gerrit-Jan
    Rea, Daniel
    Hasenburg, Annette
    Paridaens, Robert
    Hozumi, Yasuo
    Markopoulos, Christos
    Seynaeve, Caroline
    Jones, Stephen E.
    Marijnen, Corrie A. M.
    van de Velde, Cornelis J. H.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2013, 108 (02) : 190 - 196
  • [7] The tamoxifen paradoxinfluence of adjuvant tamoxifen on fracture risk in pre- and postmenopausal women with breast cancer
    Kyvernitakis, I.
    Kostev, K.
    Hadji, P.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2018, 29 (11) : 2557 - 2564
  • [8] Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
    Partridge, AH
    Wang, PS
    Winer, EP
    Avorn, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (04) : 602 - 606
  • [9] TAMOXIFEN AND COMBINATION CHEMOTHERAPY AS ADJUVANT TREATMENT IN POSTMENOPAUSAL WOMEN WITH BREAST-CANCER
    WALLGREN, A
    BARAL, E
    BELING, U
    CARSTENSEN, J
    FRIBERG, S
    GLAS, U
    KAIGAS, M
    SKOOG, L
    [J]. RECENT RESULTS IN CANCER RESEARCH, 1984, 96 : 197 - 203
  • [10] THE EFFECT OF LEVONORGESTREL INTRAUTERINE SYSTEM ON ENDOMETRIUM IN POSTMENOPAUSAL WOMEN WITH BREAST CANCER ON TAMOXIFEN THERAPY
    Davas, Inci
    Sevuk, Asuman
    Varolan, Ahmet
    Baksu, Basak
    Akyol, Atif
    Yazgan, Ali
    [J]. TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 3 (02) : 105 - 111
12345